<bill session="115" type="s" number="1049" updated="2017-06-19T22:15:21Z">
  <state datetime="2017-05-04">REFERRED</state>
  <status>
    <introduced datetime="2017-05-04"/>
  </status>
  <introduced datetime="2017-05-04"/>
  <titles>
    <title type="short" as="introduced">Opioid Addiction Risk Transparency Act</title>
    <title type="short" as="introduced">Opioid Addiction Risk Transparency Act</title>
    <title type="official" as="introduced">A bill to allow the Secretary of Health and Human Services to require that risk evaluation and mitigation strategies for certain drugs include communication plans that provide information about drug formulations or properties described in the drug labeling.</title>
    <title type="display">Opioid Addiction Risk Transparency Act</title>
  </titles>
  <sponsor bioguide_id="H001076"/>
  <cosponsors>
    <cosponsor bioguide_id="Y000064" joined="2017-05-04"/>
  </cosponsors>
  <actions>
    <action datetime="2017-05-04">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-05-04" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="115" relation="unknown" number="934"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
